Granules Pharmaceuticals clears US FDA audit
The GPI facility was inspected by the FDA from 24th to 28th January, 2022 for two of its product applications filed
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Granules Pharma
Granules India gets US FDA nod for generic Prazosin Hydrochloride capsules
These capsules are bioequivalent to the reference listed drug product, Mini plus capsules 1mg, 2mg and 5mg of Pfizer Inc
Granules Pharmaceuticals clears US FDA audit
The company had undergone the PAI audit by the US Food and Drug Administration (FDA) from 21st June, 2021 to 25th June, 2021
Granules Pharma receives US FDA approval for Ramelteon tablets
They are used for the treatment of insomnia characterised by difficulty with sleep onset